Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The aim of this interventional, randomized, double-blind, monocentric, cross-over study is to
quantify the possible deleterious effect on the cardiac autonomic nervous system control of
two long-acting anticholinergic bronchodilatators (tiotropium and glycopyrronium) and one
beta-2 agonist long-acting bronchodilatator (indacaterol ) in patients with mild COPD.